Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I did the same and I have a lot of shares. I am tired of management continuing to dilute the number of shares so they can give themselves more..
John_Galt
@BioLunacyJG
$AUPH For those that think it's a $1B/yr drug, think bigger!
COWEN: "our recent survey indicates that clinicians plan on treating roughly 45% of their pts with Lypkynis within 3 years...which would more than double the 15,000 LN patient target that is necessary to reach $1B+."
Thank you for the gift....just bought 4000 more shares.
Probably like a few here....stock rich cash poor and owe for taxes. Not a big deal.....
I totally agree. If you are in a strong financial shape, it makes a big difference in my opinion when people want to talk to you about a BO.
Per Twitter.....auph target of unusually large options trading.
$auph outperform by Cowen pt $30...twitter this morning
I posted it the other day as they were talking on CNN about the drug being in short supply. Did you know 300,000 people use it for Lupus as well as other autoimmune diseases. My initial thought was this might get the ball rolling to approve our drug earlier. Also, could auph try our drug on coronavirus....
I thought it was interesting but on the local news they said there was a shortage of hydroxychloroquine,, the malaria drug which is being used in tests for the coronavirus, but it is also used for people with Lupus. Six pharmacies in the local area had none.
Watching the action today is very frustrating as these computer to computer trades are doing nothing. They need to be going up....not down.
I remember the conversation on the ARIA board when we received the BO offer. Many sold their stocks early and were able to get into this stock a little cheaper. I waited as I had 115,000 shares of Aria and was able to get the full amount whereas many did not. The punishment I received was a higher price I paid for Auph. I have 215,475 shares at an average price of $5.666. I am still very happy.
I think the selling is over.....we might finish green with a little luck.
If I was BP and interested in acquiring Auph, I would buy every one of those shares.
There is a squeeze coming....
You make me feel a bit greedy with my 215,000 plus shares. I have no plans to sell until we get a buyout.
We have one special person who led the Ariad group here but was banned.
In my opinion, this is an excellent indicator of things to come. It is an expensive waste of time hiring high level individuals if they know this trial is going to fail. I am so happy I am not a person holding a short position as the clock is ticking.
Just curious.....do you think BR there was a leak that the phase 3 trial was successful???
Alban119 aka as BR. Thank you for your insight but most of us know who BR is and totally ignore most of his comments.
I would not be happy!!!
Not me....I am looking for at least double that amount.
Darn spell check...ARAID
Afraid was bought out at $24 a share....5.2 billion. If AUPH is bought out at $60 a share, that would be 5.4 billion.
I remember with Ariad we use to get some feedback from patients taking those drugs. Have not seen that on this drug yet...
I remember those great days....four days in a row Jim Cramer bad mouth this stock. On day 4, I looked the stock up and was surprised it was selling for $1.64 a share. I bought 30,000 shares over the next few days between $1.64 - $2.24. A few days later, Sheldon bought a massive amount of shares and the stock started climbing. I still own most of those shares. Ty Jim
I hate this merger and voted NO....200,000 shares
What confuses me is the lack of volume. Not many sellers at this price range!!
I suspect we will see little movement up on the share price as the hedge funds are working overtime trying to get as many shares as possible. Cramer and his friends have down a wonderful job making it appear this deal is dead. They are masterful in creating fake news and getting it put on CNBC. If you are not loading up on additional shares, you will be regretting it later. Have not heard one negative comment about this merger from RAD, WBA or Fred.
With Fred being down so much today, makes you wonder if the FTC is going to approve WBA to buy all of RAD without having to sell any of the stores and sending Fred to take a cold shower.
You know it is getting close when you check your account and ARIA is no longer listed by name.
A Form CT ORDER regarding ARIAD Pharmaceuticals, Inc. has been filed with the United States Securities and Exchange Commission.
To View the filing please click here
If you are unable to click on the link above, please copy and paste the URL below into a web browser
http://investor.ariad.com/phoenix.zhtml?c=118422&p=IROL-sec
NASDAQ OMX 325 Donald J. Lynch Blvd, Marlborough, MA 01752 | 800/990-6397
Click Here to unsubscribe from this JoinMail list.
I suspect Vanguard is buying shares and keeping the lid on any increase until they get their desired amount.
That is a huge increase from what they had on June 30, 2015. 9,325,187 shares.
Which makes me wonder if they controlled the votes for this next meeting and something came up like a buyout offer, would they be allowed to vote the shares....
They did not use the words like tender or surrender. They just offered to vote my shares for me and I told them I use e-trade and I would be voting them. I had some people talking to me when I got the call and I was not interested in chatting with them at that time,
That is who called me too.....I do not know who they are.
Received my first call wanting to handle my proxy vote. Anyone else get a call yet?
I am in your corner on this discussion. When I first read that article a few days ago, I thought it was old news published by some shorts trying to being down the share price. All you have to do is look at the dates and realize this was when ARIAD was having a most difficult time.
As to whether I plan to stay with HB, it is still too close to call. I have 115,000 shares so I am not in a big hurry to make up my mind. I wonder how many shares a few of these other people have who spend so much time on this board.really have......
This could be huge.....TASIGNA (nilotinib)
http://www.examiner.com/article/new-research-points-to-tau-protein-malfunction-as-cause-of-alzheimer-s
Big Upside Potential for Ariad Pharmaceuticals, Inc. (ARIA)
October 03, 2014
Dr. Y. Katherine Xu, Analyst with William Blair & Co., says Ariad Pharmaceuticals, Inc. (ARIA) has the potential for 100% upside from current levels. She says the stock is being ignored by investors because its leukemia drug, Iclusig, was suspended from marketing because of safety issues, but has now been relaunched with some safety precautions.
“People felt that it was a tainted story,” Xu says. “But I think, in the end, this is the most potent drug for this particular leukemia, and after patients failed all the other therapies, the patients will come to this drug, and then with good management of side effects and effective dosage reduction, this drug should be used in most patients and make a difference.”
FOR MORE INFORMATION ON THIS INTERVIEW CLICK HERE.
Xu says she thinks Ariad’s sales from Iclusig could peak at $700 million. Since the stock has been ignored for quite some time, she says now is a good time to enter.
“Since the relaunch, a lot of doctors have been using the drug at lower doses, and it seems to be fine,” Xu says. “It’s basically about informing the market and practitioners and patients well about the safety profile and how to manage the adverse events. And then eventually, if you talk to doctors, they’re like well, after patients fail all the other therapies, this is the only option.”
- See more at: http://www.twst.com/news/1556-big-upside-potential-for-ariad-pharmaceuticals-inc-aria#sthash.cfnm3pRz.dpuf